UCB (EBR:UCB) UCB Media Room - Transparency notification FMR LLC

Directive transparence : information réglementée

05/08/2022 20:05
https://mb.cision.com/Public/18595/3610818/b8115ff58f13dacd_800x800ar.png ** Transparency notification FMR LLC ------------------------------------------------------------ Brussels (Belgium), 5 August 2022 =E2=80=93 20:05 (CEST) =E2=80=93 Regulate= d information 1. Summary of the notification Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large = shareholdings, UCB=C2=A0SA/NV announces that it received a transparency not= ification from FMR LLC. (having its registered office at The Corporation Tr= ust Center, 1209 Orange Street, Wilmington, New Castle County, Delaware, 19= 801, U.S.A.) on 3 August 2022. FMR LLC., notified that, following a disposal of UCB=C2=A0shares with votin= g rights by its affiliates, the shareholding in UCB SA/NV of a controlled e= ntity decreased and crossed downwards the 3% threshold, on 1 August 2022. On 1 August 2022, FMR LLC. (taking into account the holding of its affiliat= es) owned 7 509 016 UCB=C2=A0shares with voting rights, representing 3.86% = of the total number of shares issued by the company (194 505 658), versus 4= .99 % (9 698 901 UCB shares) in the previous notification dated 24 May 2022= . 2. Content of the notification =C2=B7 Reason for the notification: Acquisition or disposal of voting secur= ities or voting rights. =C2=B7 Notification by: A parent undertaking or a controlling person. =C2=B7 Persons subject to the notification requirement: https://mb.cision.com/Public/18595/3610818/abf09884c5075e09_800x800ar.png =C2=B7 Date on which the threshold is crossed: 1 August 2022. =C2=B7 Threshold crossed (in %): 3%. =C2=B7 Denominator: 194 505 658. =C2=B7 Notified details: https://mb.cision.com/Public/18595/3610818/b07ffbdadf650483_800x800ar.png =C2=B7 Chain of controlled undertakings through which the holding is effect= ively held: =E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2= =80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8Bhttps://mb.cision.com/Pu= blic/18595/3610818/817e4c5acee4c837_800x800ar.png =C2=B7 Additional information: The holdings attributed to the entities ment= ioned in heading 10 arise from holdings of various undertakings for collect= ive investment that are managed by FIAM LLC, Fidelity Institutional Asset M= anagement Trust Company, Fidelity Management & Research Company LLC, Fideli= ty Management Trust Company, FMR Investment Management (UK) Limited and Str= ategic Advisers LLC each of which are entities that are subsidiaries of and= controlled by FMR LLC. The entities mentioned in heading 10 are the discre= tionary investment managers and exercise the voting rights at their discret= ion in the absence of specific instructions. Threshold crossed by a Control= led Undertaking. 3. Further information This press release and the detailed transparency notification are available= on UCB=C2=A0SA/NV=E2=80=99s website via the following link (https://www.uc= b.com/investors/UCB-shareholders/Transparency-notifications) . An updated overview of the UCB=C2=A0SA/NV large shareholdings will be avail= able on UCB=C2=A0SA/NV=E2=80=99s website via the following link (https://ww= w.ucb.com/investors/UCB-shareholders) . For further information, contact UCB: Investor Relation Antje Witte T +32 2 559 94 14 antje.witte@ucb.com (mailto:antje.witte@ucb.com) Corporate Communications Laurent Schots T+32 2 559 92 64 =E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8B=E2=80=8Blaurent.scho= ts@ucb.com (mailto:laurent.schots@ucb.com) =C2=A0=C2=A0=C2=A0=C2=A0=C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With approximately 8 600 peopl= e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.8 bi= llion in 2021. UCB is listed on Euronext Brussels (symbol: UCB). Follow us = on Twitter: @UCB_news Image FMR LLC (https://mb.cision.com/Public/18595/3610818/abf09884c5075e09_org.pn= g) Image Notified details (https://mb.cision.com/Public/18595/3610818/b07ffbdadf6504= 83_org.png) Image Chain of controlled undertakings through which the holding is effectively h= eld (https://mb.cision.com/Public/18595/3610818/817e4c5acee4c837_org.png) G= enericFile 220805 - PB Transparantieverklaring FMR LLC (https://mb.cision.com/Public/1= 8595/3610818/bd54f6ffefc36555.pdf) GenericFile 220805 - PR Transparency notification FMR LLC (https://mb.cision.com/Public= /18595/3610818/b081bfb55585e1b4.pdf) GenericFile 220805 - CdP Notification de transparence FMR LLC (https://mb.cision.com/Pu= blic/18595/3610818/9a5072d795d4cd14.pdf) ______________________ If you would rather not receive future communications from UCB SA, please g= o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x112836x1x6868579x2400= 0x6&Email=3Dregnews%40symexglobal.com. UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium